SCHEMBL17871687

SCHEMBL17871687

CC1(C)OB(c2ccc3c(c2)C(F)(F)c2cc(C(=O)CCl)ccc2-3)OC1(C)C

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA1 P00915 3/20 0.36
▸ CA2 P00918 3/20 0.36
▸ CA9 Q16790 3/20 0.36
▸ ROCK1 Q13464 1/20 0.36
▸ GSK3B P49841 1/20 0.35
▸ ALDH1A1 P00352 2/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ P4HB P07237 1/20 0.34
▸ LIPG Q9Y5X9 4/20 0.34
▸ LPL P06858 3/20 0.34
▸ F11 P03951 3/20 0.34
▸ F2 P00734 2/20 0.34
▸ PRSS1 P07477 2/20 0.34
▸ PRSS2 P07478 2/20 0.34
▸ PRSS3 P35030 2/20 0.34
▸ HIF1A Q16665 2/20 0.33
▸ MAPT P10636 1/20 0.33
▸ BACE1 P56817 1/20 0.32
▸ BACE2 Q9Y5Z0 1/20 0.32
▸ AAK1 Q2M2I8 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23294563 0.82 LPL (0.47) CA1CA2CA9ROCK1LIPG
SCHEMBL29914599 0.82 LPL (0.47) CA1CA2CA9ROCK1LIPG
SCHEMBL28270044 0.75 PDK2 (0.47) GSK3BALDH1A1HIF1A
SCHEMBL2708516 0.74 GSK3B (0.42) CA1CA2CA9GSK3BALDH1A1
SCHEMBL19792212 0.74 GSK3B (0.42) GSK3BALDH1A1KDM4EHIF1AMAPT
SCHEMBL16891264 0.73 LPL (0.47) CA1CA2CA9ROCK1LIPG
SCHEMBL22859291 0.71 CA12 (0.42) CA1CA2CA9ALDH1A1LIPG
SCHEMBL13855297 0.71 PDK2 (0.42) CA1CA2CA9ROCK1P4HB
SCHEMBL69358 0.70 LIPG (0.47) CA1CA2CA9P4HBLIPG
SCHEMBL29506426 0.70 LIPG (0.47) CA1CA2CA9P4HBLIPG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016103232-A1 AN IMPROVED PROCESS FOR THE PREPARATION OF HCV INHIBITOR GRANULES INDIA LIMITED (IN) 2016-06-30 — — WO disclosed
Send feedback